Shandong Weigao Group Medical Polymer Co (UK2) Stock Statistics & Valuation Metrics

Shandong Weigao Group Medical Polymer Co has a market cap or net worth of EUR 1.66B. The enterprise value is EUR 11.73B.

Market Cap

EUR 1.66B

Enterprise Value

EUR 11.73B

Shandong Weigao Group Medical Polymer Co has 4,522,332,500 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

4,522,332,500

Owned by Insiders

―

Owned by Institutions

12.38%

Shandong Weigao Group Medical Polymer Co’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 4.60%.

Return on Equity (ROE)

0.07

Return on Assets (ROA)

0.04

Return on Invested Capital (ROIC)

4.60%

Return on Capital Employed (ROCE)

0.06

Revenue Per Employee

1.01M

Profits Per Employee

121.13K

Employee Count

13,310

Asset Turnover

0.37

Inventory Turnover

2.81

The current PE Ratio of Shandong Weigao Group Medical Polymer Co is 9.44. Shandong Weigao Group Medical Polymer Co’s PEG ratio is -0.33.

PE Ratio

9.44

PS Ratio

0.94

PB Ratio

0.53

Price to FCF

11.73

Price to Operating Cash Flow

4.57

PEG Ratio

-0.33

In the last 12 months, Shandong Weigao Group Medical Polymer Co had revenue of 13.39B and earned 1.61B in profits. Earnings per share was 0.35.

Revenue

13.39B

Gross Profit

6.33B

Operating Income

1.70B

Pretax Income

2.03B

Net Income

1.61B

EBITDA

2.83B

Earnings Per Share (EPS)

0.35

In the last 12 months, operating cash flow was 2.80B and capital expenditures -1.73B, giving a free cash flow of 1.08B billion.

Operating Cash Flow

2.80B

Free Cash Flow

1.08B

Free Cash Flow per Share

0.24

Shandong Weigao Group Medical Polymer Co pays an annual dividend of ―, resulting in a dividend yield of 5.12%

Dividend Per Share

―

Dividend Yield

5.12%

Payout Ratio

N/A

Free Cash Flow Yield

8.42%

Earnings Yield

10.54%

Beta

0.24

52-Week Price Change

-41.20%

50-Day Moving Average

0.33

200-Day Moving Average

0.38

Relative Strength Index (RSI)

50.33

Average Volume (3m)

4

Shandong Weigao Group Medical Polymer Co upcoming earnings date is Mar 30, 2027, TBA (Not Confirmed).

Last Earnings Date

Aug 25, 2026

Next Earnings Date

Mar 30, 2027

Ex-Dividend Date

―

Shandong Weigao Group Medical Polymer Co as a current ratio of 3.78, with Debt / Equity ratio of 24.83%

Current Ratio

3.78

Quick Ratio

3.32

Debt to Market Cap

0.23

Net Debt to EBITDA

-1.06

Interest Coverage Ratio

6.82

In the past 12 months, Shandong Weigao Group Medical Polymer Co has paid 320.79M in taxes.

Income Tax

320.79M

Effective Tax Rate

0.16

Shandong Weigao Group Medical Polymer Co EV to EBITDA ratio is 3.56, with an EV/FCF ratio of 9.25.

EV to Sales

0.74

EV to EBITDA

3.56

EV to Free Cash Flow

9.25

EV to Operating Cash Flow

3.56

Shandong Weigao Group Medical Polymer Co has EUR 8.92B in cash and marketable securities with EUR 4.96B in debt, giving a net cash position of EUR 3.96B billion.

Cash & Marketable Securities

EUR 8.92B

Total Debt

EUR 4.96B

Net Cash

EUR 3.96B

Net Cash Per Share

EUR 0.88

Tangible Book Value Per Share

EUR 4.77

Gross margin is 45.56%, with operating margin of 12.13%, and net profit margin of 10.13%.

Gross Margin

45.56%

Operating Margin

12.13%

Pretax Margin

13.51%

Net Profit Margin

10.13%

EBITDA Margin

20.72%

EBIT Margin

13.22%

The average price target for Shandong Weigao Group Medical Polymer Co is EUR 0.52, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

EUR 0.52

Price Target Upside

50.03% Upside

Analyst Consensus

Moderate Buy

Analyst Count

6

Revenue Growth Forecast

-0.09%

EPS Growth Forecast

-32.00%

Smart Score

4

AI Score

―